Skip to search formSkip to main contentSkip to account menu

ramucirumab

Known as: Anti-TRAIL Receptor 2 Monoclonal Antibody HGS-ETR2, Monoclonal Antibody HGS-ETR2, anti-TRAIL R2 mAb HGS-ETR2 
A recombinant, fully human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2) with antiangiogenesis… 
National Institutes of Health

Related topics

Related topics

13 relations
10 ML ramucirumab 10 MG/ML Injection [Cyramza]Inhibition of Cell ProliferationNCIt Antineoplastic Agent TerminologyPositive Regulation of Apoptosis

Narrower (3)

Anti-VEGFR-2 Fully Human Monoclonal Antibody IMC-1121BCyramzaIMC 1121B

Broader (2)

Antineoplastic AgentsMonoclonal Antibodies

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial
AbstractBackgroundREACH evaluated ramucirumab in the second-line treatment of patients with advanced hepatocellular carcinoma. In… 
Review
2015
Review
2015
Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight.
Review
2014
Review
2014
Systemic treatment.
Review
2011
Review
2011
Targeting angiogenesis in esophagogastric adenocarcinoma.
The possibility of targeting tumor angiogenesis was postulated almost 40 years ago. The vascular endothelial growth factor (VEGF… 
2006
2006
HGS-ETR2-A fully human monoclonal antibody to TRAIL-R2: Results of a phase I trial in patients with advanced solid tumors.
3012 Background: HGS-ETR2 is a fully-human high-affinity monoclonal antibody that is agonistic to the Tumor Necrosis Factor… 
2006
2006
Functional expression of TRAIL receptors TRAIL-R1 and TRAIL-R2 in esophageal adenocarcinoma.
2005
2005
HGS-ETR1, a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1…
3052 Introduction: HGS-ETR1 (TRM-1) is a fully human monoclonal antibody that is agonistic to the R1 (TRAIL-R1 or DR4) receptors… 
2004
2004
Phase I study of a fully human monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand death receptor 4 (TRAIL-R1) in subjects with advanced solid malignancies or non…
2533 Background: TRAIL is a member of the TNF ligand superfamily. There is strong evidence for its ability to induce apoptosis in… 
2002
2002
Tissue distribution of different mercurial compounds analyzed by the improved FI-CVAAS.
Mercury contents in biological samples can be measured by cold vapor atomic absorption spectroscopy combined with the flow… 
2000
2000
Piassava fibers (Attalea funifera): NMR spectroscopy of their lignin
Lignin of piassava (Attalea funifera) was analyzed by 1H- and 13C-NMR spectroscopy. The HGS-nature of this lignin was confirmed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)